# Everolimus

NDC: 0093-7769
Generic name: Everolimus
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20231023
Marketing ended: 20260930
FDA application: ANDA210050

## Active ingredients

- EVEROLIMUS: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-7769"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-7769
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3bca36b-29ed-4a2b-a1be-a57b6af805f6